CRISPR Cas9 library screen in primary T cells diffuse large B cell lymphoma cells to identify modulators in tumor-immune interaction
Validation of the Combinatorial Effect of Blinatumomab and Nivolumab in Caner Therapy
Unlocking the potential of DEL | Inspire Hit Discovery
Interview of Dr. Xuanjia Peng
Faster with high-speed fragment screening —Accelerate your drug discovery campaign
Drug Hunter: Discovering New Frontiers in Cancer Treatments & Beyond
Interview of Dr. Phil Jones, VP of Therapeutics Discovery
Specialty Chemistry Platform and Capabilities at WuXi AppTec RSD
Cutting-edge synthetic technology and expertise in special chemical matters
Merging a Passion for Biochemistry, Synthetic Chemistry, and Bioactive Molecules in Academia
Interview of Dr. Joseph Ready, Co-Founder, Rodeo
In vivo CRISPR Animal Models
High efficiency genome editing service for drug discovery
Empowering Chemistry with Quantum Mechanics
WuXi’s RSD teams are applying and developing QM calculations in multiple areas for organic syntheses
Shifting the Paradigm of Resistance and Undruggables for Unmet Medical Needs in Cancer, Neuroscience, and Beyond
Interview of John Houston, Arvinas
DELopen: DNA Encoded Library (DEL) Platform Offering more than 2.8 Billion Compounds
Apply for DNA-Encoded Library compound for free
OncoWuXi Database: To Facilitate Oncology Drug Discovery and Translational Oncology
Providing a portable oncology database for selection and inquiry of 1,000+ models for cancer research
DELopen Promotes Worldwide Academic Research Using DNA-Encoded Libraries, Far More Than Just a Numbers Game
Interview of Dr. Richard Lerner